Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elevate: PK and Safety of rFVIIIFc (15K Scale) in Severe Hemophilia A
NCT02502149Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2015
- Primary completion
- Apr 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 3 trial of eftrenonacog alfa in hemophilia A, sponsored by Sanofi. Started Aug 2015; status: completed.
02
Drugs
eftrenonacog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02502149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502149.